Contact Us Today|info@empharmd.com

Can Agents for Hereditary Angioedema Be Used to Avoid Intubation in Patients Presenting with a Compromised Airway?

A middle-aged male with no known history of hereditary angioedema (HAE) and a questionable medication history presents to your ED with oropharyngeal angioedema. He has received the usual cocktail of intramuscular epinephrine along with an intravenous antihistamine, H2-receptor antagonist, and corticosteroid with no improvement in symptoms. The EM resident asks you for the correct dose of C1-esterase inhibitor (C1-INH). Oh, and it is needed STAT because the decision has been made to perform rapid sequence [...]

By |2015-04-01T09:00:00-05:00April 1st, 2015|EM PharmD Blog|0 Comments

Liberal Changes to rt-PA Contraindications for Acute Ischemic Stroke

Flying in under the radar recently were the changes to the Alteplase (rt-PA) prescribing information. These changes pertain to the contraindications to use of the drug in acute ischemic stroke. It's hard to find anything on the particulars about why the FDA authorized such changes, and more puzzlingly, why.The updated contraindications now read as follows: LinkDo not administer Activase to treat acute ischemic stroke in the following situations in which the risk of bleeding is [...]

By |2015-03-31T14:51:00-05:00March 31st, 2015|EM PharmD Blog|0 Comments

Advice to Future Residents From the Ghost of a Skeptical Student’s Past

When I began pharmacy school several years ago the thought of pursuing a residency wasn’t even on the radar. Like most other students at the time, I had a community pharmacy background and when the topic of post-graduate education was introduced I questioned its utility. I asked the important questions. Do I see myself working in a clinical setting? Is the extra year(s) of work and countless projects really worth it? Seriously you guys, who [...]

By |2015-03-03T19:16:00-05:00March 3rd, 2015|EM PharmD Blog|0 Comments

VRE: A Very Real Emergency Medicine Problem

With increasing prevalence of antimicrobial resistance among bacteria coupled with the lack of novel antimicrobial development, multi-drug resistant bacteria will continue to be problematic [1]. Due to this increased prevalence, it is likely that even in the emergency department, we will see more and more patients with prior cultures or past medical history documentation of multi-drug resistant bacteria, such as vancomycin resistant Enterococcus (VRE). Once we are aware of this information, how should this affect [...]

By |2015-02-19T11:00:00-05:00February 19th, 2015|EM PharmD Blog|0 Comments

Throwback Drug Thursday: Sus-Phrine, An Aqueous Formulation of Epinephrine

Note: This is the introduction of a series of posts on Emergency Medicine PharmD called "Throwback Drug Thursdays" (#TBDT). It will feature medications that were once available for routine use in the emergency department, but are no longer on the market.   I work with some awesome providers within my emergency department, many of whom have been practicing for quite some time. Sometimes, they will reminisce back to their time during residency, especially the interesting [...]

By |2015-02-12T14:45:00-05:00February 12th, 2015|EM PharmD Blog|0 Comments

Pharmaceutical education: Are we THAT far behind?… Yea pretty much.

I watched TRON over the weekend (yes, both the original and re-boot). If you’re familiar with the story, TRON was born in technology and “fights for the User.” I feel that the community of FOAM is taking on the role of TRON, and is fighting for the User/consumer/student of medical education. Often times, we are quite literally fighting (albeit minus a light cycle).It’s pretty easy now to get a colleague in the emergency department (pharmacist, [...]

By |2015-01-15T19:36:00-05:00January 15th, 2015|EM PharmD Blog|0 Comments

Historical Articles in Emergency Medicine Pharmacy

Within our respective specialties, we often set our sights to new beginnings and adventures. With the passage of the resolution 44 by the American College of Emergency Physicians this past October and a recent post written by Bryan Hayes (@PharmERToxGuy) on Academic Life in Emergency Medicine describing in detail the training of EM pharmacists, I have been contemplating the general progression of the initiation and establishment of emergency medicine pharmacy, with ideas mainly surrounding the theme of "Where [...]

By |2015-01-08T10:00:00-05:00January 8th, 2015|EM PharmD Blog|0 Comments

Taking Conference Tweeting to the Next Level: From the Speaker’s Perspective

Live conference tweeting has grown to become quite commonplace in recent years. Conference organizers will often designate a specific hashtag for enhanced and engaged communication among attendees and non-attendees alike during the day(s) of the conference. Some of the basic concepts related to live conference tweeting have been discussed by Nikita Joshi (@njoshi8) and Bryan Hayes (@PharmERToxGuy) on the Academic Life in Emergency Medicine blog, and Rob Rogers (@EM_Educator) hosted a pro-con debate related to [...]

By |2014-12-30T10:50:00-05:00December 30th, 2014|EM PharmD Blog|0 Comments

EMPOWER Episode 5 – Global Pharmacy Practice: Comparisons of USA versus Canada

In this episode of what will hopefully become a series covering topics related to global pharmacy practice, we have featured Mark McIntyre, an EM pharmacist who practices at Mount Sinai Hospital in Toronto, Ontario, Canada.Listen to the podcast by clicking the link below (link available on iTunes here):EMPOWER Episode 5 - Global Pharmacy Practice: Comparisons of USA versus CanadaShow Notes: Time Topic 0:00-0:26 Musical Introduction 0:26-3:09 Introduction to episode featuring Mark McIntyre, PharmD 3:10 Culture [...]

By |2014-12-19T18:32:00-05:00December 19th, 2014|EM PharmD Blog|0 Comments

Introduction to the Assertion-Evidence Slide Design

In recent months of giving presentations to both future and seasoned pharmacy practitioners, I have been able to garner a new category of feedback from audience members that was never the case previously. It has been quite interesting to gain a new focus of feedback for my presentations, but I think it speaks volumes to how far we have come and how far we need to go when it comes to the provision of medical [...]

By |2014-11-18T11:10:00-05:00November 18th, 2014|EM PharmD Blog|0 Comments